New cancer drug enters first human testing
Disease control
Recruiting now
This is the first study testing the experimental cancer drug ADCX-020 in people. Researchers will give increasing doses to 290 adults with advanced solid tumors that have spread or returned after standard treatments. The main goals are to find a safe dose and see early signs of w…
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC